Skip to content

EBIT at other companies

InfuSystem Holdings logo
InfuSystem HoldingsINFU
$1.59M+157%
Haemonetics logo
HaemoneticsHAE
$67.4M+14.2%
Teladoc Health logo
Teladoc HealthTDOC
-$61.77M+48.8%
Baxter International logo
Baxter InternationalBAX
DaVita logo
DaVitaDVA
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-75.5%
Enterprise value$151.13M-61.9%
P/S0.7×-2.1×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Return on equity-53.2%-14.8pp
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Calculated from Outset Medical, Inc.’s reported figures.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s EBIT?
Outset Medical, Inc. (OM) reported EBIT of -$16.92M in Q1 2026.
How has Outset Medical, Inc.'s EBIT changed year-over-year?
Outset Medical, Inc.'s EBIT decreased by 3.2% year-over-year, from -$16.4M to -$16.92M.
What is the long-term trend for Outset Medical, Inc.'s EBIT?
Over 4 years (2021 to 2025), Outset Medical, Inc.'s EBIT has grown at a -15.4% compound annual growth rate (CAGR), from -$130.52M to -$66.71M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.